Paterson Institute for Cancer Research SCIENTIFIC REPORT 2005

72
Acknowledgement for Funding of the Paterson Institute
The major source of funding (82%) of the Paterson Institute is through a core grant from Cancer Research
UK (CR-UK). This is divided between the various scientific groups and service units within the Institute
to enable them to carry out their research. In addition to this a further 5% of funding has been received
from CR-UK for Project Grant Work and Studentships.
4%
1%
6%
The infrastructure of the Institute is funded by the Christie Hospital Endowment Fund and together with
specific project grants accounts for 6% of the total income.
The final 7% of the funding is received from a number of additional sources. The research carried out
through these additional projects enhances and supports the research undertaken by the core funding.
These sources are as follows:
PATERSON INSTITUTE FUNDING 2005
• National Translational Cancer Research Network (NTRAC)
• European Commission
• Medical Research Council
• Association of International Cancer Research
• Wellcome Trust
• Astra Zeneca
• European Molecular Biology Organisation
• Novartis
• Friends of Rosie
We are immensely grateful to all our sponsors.
7%
82%
CRUK Core Grant
CRUK Project Grants
CRUK Student Grants
Christie Hospital Endowment Fund
Other Sources
P A T E R S O N I N S T I T U T E S C I E N T I F I C R E P O R T 2 0 0 5